Building a Comprehensive Sickle Cell Disease Program in Western Kenya: A Decade of Experience and Growth

Area of Science:

• Global Health
• Pediatrics
• Hematology

Background:

• Sickle Cell Disease (SCD) affects approximately 515,000 infants globally each year, with 80% born in Sub-Saharan Africa (SSA).
• High mortality rates (50%-80% before age 5) in SSA are linked to inadequate comprehensive SCD care.
• The Academic Model Providing Access to Healthcare (AMPATH) SCD Program was established in Kenya in 2010 to enhance SCD care access.

Purpose of the Study:

• To improve access to comprehensive Sickle Cell Disease care in resource-limited settings.
• To increase healthcare capacity for managing SCD through training, clinical support, research, and advocacy.
• To develop a replicable model for SCD care programs in high-burden areas.

Main Methods:

• Training over 5,000 healthcare workers via face-to-face, virtual, and mentorship programs.
• Implementing early infant screening for SCD.
• Facilitating access to essential medications such as hydroxyurea and antibiotics.

Main Results:

• Significant capacity building in SCD management among healthcare professionals.
• Improved clinical care through early detection and medication support.
• Active participation in research and advocacy for comprehensive SCD services.

Conclusions:

• The AMPATH SCD Program's strategies provide a viable template for establishing similar programs in resource-limited environments.
• Successful implementation of training, screening, and medication access can significantly improve outcomes for children with SCD.
• The program demonstrates the effectiveness of multi-faceted approaches in addressing the challenges of SCD care in Sub-Saharan Africa.